The Bulletin
Men's Weekly


.

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

  • Written by PR Newswire
MedAlliance SELUTION SLR Receives Second FDA IDE Approval

GENEVA, Aug. 10, 2022 /PRNewswire/ -- SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femoral artery (SFA).

MedAlliance SELUTION SLR Receives Second FDA IDE ApprovalMedAlliance SELUTION SLR Receives Second...

The Bulletin Magazine

The Benefits of Consulting with Commercial Property Lawyers Before a New Development

The Fine Line Between Self-Defense and Assault in Criminal Law

Understanding the Importance of Electrical Thermal Imaging and Switchboard Thermal Imaging

How to Raise Kinder Kids in a World That Moves Too Fast

The Rise of the JackJumpers

Protecting Lone and Isolated Workers: Dangers and Safety Solutions for Those Dealing with the Public

The Power of Pull-Up Banner: A Versatile Tool for Effective Marketing

6 Signs of Competent & Professional Lawyers in Melbourne

House Packing Services: Why Professional Packers to Save You Time and Stress